Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

Introduction Mortality and disability in diabetes mellitus are determined mostly by cardiovascular complications and cancer. The impact of dipeptidyl peptidase-4 inhibitor (DPP-4i) and sodium-glucose cotransporter-2 inhibitor (SGLT2i) monotherapy or combination on long-term complications of type 2 d...

Full description

Saved in:
Bibliographic Details
Main Authors: Gyula Poór, Gábor Sütő, Gergő A Molnár, Gyorgy Rokszin, Ibolya Fábián, Zoltan Kiss, György Jermendy, Peter Kempler, István Wittmann
Format: Article
Language:English
Published: BMJ Publishing Group 2021-10-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/9/1/e001765.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items